Comments
Aarti Drugs Limited’s shares increased by 16.30 per cent, following the recent announcement of the company’s equity share buyback.
In the Board meeting held on July 21, 2023, Aarti Drugs Limited approved the buyback of 6,65,000 Equity Shares, representing 0.72 per cent of the existing paid-up capital, for ₹ 900 per equity share. The actual number of securities bought back will be intimated post-buyback.
The shares went up by 16.30 per cent to Rs. 593.85 at 11:11 a.m. on BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.